8-K: Celanese Corporation Reports Mixed Q2 Results Amidst Supply Disruptions, Engineered Materials Achieves Record EBIT

Celanese Corporation's second quarter 2024 results show a sequential improvement in earnings, driven by cost-cutting measures and strong performance in Engineered Materials, but were hampered by significant supply chain disruptions and weak demand in key markets.

Summary

• Celanese Corporation reported second quarter 2024 adjusted earnings of $2.38 per share, which includes a $0.30 per share impact from Mobility & Materials transaction amortization, representing a 14 percent sequential increase.
• The company faced significant headwinds from supplier disruptions, leading to force majeure declarations for acetic acid and VAM in the Western Hemisphere, impacting their lowest-cost U.S. Gulf Coast production facilities.
• Engineered Materials (EM) achieved record quarterly adjusted EBIT of $265 million and record operating EBITDA of $375 million, with a 32 percent sequential increase in adjusted EBIT.
• The Acetyl Chain (AC) segment experienced a 5 percent sequential decrease in net sales, with a 1 percent decline in volume and a 4 percent decline in price, due to supplier outages and weak demand.
• The company expects third quarter adjusted earnings per share to be between $2.75 and $3.00, and has revised its full-year adjusted earnings per share guidance to $10.25 to $10.75.
• Free cash flow for the second quarter was $173 million, and the company anticipates full-year free cash flow to approach $1.1 billion.
• Celanese is focused on deleveraging and expects to see an acceleration in progress towards a 3X leverage ratio in the second half of 2024.

Sentiment

Score: 5

Explanation: The document presents a mixed picture with strong performance in Engineered Materials offset by significant challenges in the Acetyl Chain and overall market conditions. The revised guidance and supply chain issues temper the positive aspects.

Positives

• Engineered Materials achieved record quarterly adjusted EBIT and operating EBITDA, demonstrating the success of strategic initiatives.
• The company saw a 32 percent sequential improvement in Engineered Materials adjusted EBIT.
• Celanese is on track to deliver $150 million in synergies for 2024, with $40 million captured in the first half of the year.
• The company is making progress on cash repatriation and deleveraging plans.
• Free cash flow is expected to increase significantly in the second half of the year.
• The company's project pipeline model is driving growth in the medical and automotive sectors.

Negatives

• Significant supplier disruptions led to force majeure declarations for acetic acid and VAM, impacting production and earnings.
• The Acetyl Chain segment experienced a 5 percent sequential decrease in net sales due to supplier outages and weak demand.
• Demand in key end-markets like paint, coatings, and construction remains sluggish, with some showing negative growth rates.
• The company experienced a $25 million adjusted EBIT impact due to supplier disruptions in the Acetyl Chain segment.
• The company has revised its full-year adjusted earnings per share guidance to $10.25 to $10.75, down from previous expectations.
• The company experienced a $10 million impact due to lower than expected realization of higher margin non-contracted sales.

Risks

• Continued supplier disruptions could further impact production and earnings.
• Weak demand in key end-markets may persist, affecting sales and pricing.
• The company faces pricing pressure due to competitive dynamics and oversupply in some markets.
• The company's ability to achieve its deleveraging targets could be affected by market conditions.
• The company is exposed to risks associated with global economic conditions and geopolitical instability.
• The company is exposed to risks associated with raw material price volatility.

Future Outlook

The company anticipates a significant ramp up in earnings through the third quarter and across 2024, driven by continued execution against its action plan. They expect third quarter adjusted earnings per share of $2.75 to $3.00 and full-year adjusted earnings per share of $10.25 to $10.75. The company expects to see an acceleration across the second half of 2024 in their progress towards 3X leverage.

Management Comments

• Lori Ryerkerk stated that the second quarter results demonstrated significant and tangible improvements from the many controllable actions implemented over the past 18 months.
• Lori Ryerkerk noted that the largest headwind was a series of disruptions at two suppliers of critical raw materials.
• Scott Richardson highlighted that Engineered Materials delivered record quarterly adjusted EBIT and operating EBITDA.
• Chuck Kyrish mentioned that the company is executing against its cash repatriation and deleveraging plans.
• Lori Ryerkerk expressed confidence that the value creation building blocks will continue to gain momentum through the rest of 2024 and into 2025.

Industry Context

The report highlights the impact of global supply chain disruptions and weak demand in key industries, reflecting broader challenges faced by the chemical industry. The company's focus on cost control and strategic initiatives aligns with industry trends towards efficiency and resilience.

Comparison to Industry Standards

• Celanese's Engineered Materials segment's record EBIT performance is a positive outlier compared to peers facing similar demand headwinds.
• The Acetyl Chain segment's struggles with supply disruptions and weak demand are consistent with challenges faced by other chemical companies in the Western Hemisphere.
• The company's focus on deleveraging and cash repatriation is a common strategy among companies with high debt levels.
• The company's 3% year-over-year increase in average content per vehicle in the automotive sector, outpacing the industry's flat performance, is a strong result compared to competitors.
• The company's ability to maintain operating EBITDA margins above 25 percent in the Acetyl Chain segment for the last five years is a strong performance compared to industry averages.

Stakeholder Impact

• Shareholders will be impacted by the revised earnings guidance and the company's deleveraging efforts.
• Employees in the Engineered Materials segment may benefit from the strong performance.
• Customers may experience supply disruptions due to the force majeure declarations.
• Suppliers may be affected by the company's efforts to optimize its supply chain.
• Creditors will be impacted by the company's deleveraging plans.

Next Steps

• The company will continue to execute against its value creation initiatives.
• Celanese will focus on deleveraging and cash repatriation.
• The company will continue to evaluate divestiture opportunities.
• The company will work to normalize inventory levels as production transitions to other sites.

Key Dates

Keywords

Celanese, Engineered Materials, Acetyl Chain, EBIT, EBITDA, synergies, supply chain, force majeure, raw materials, deleveraging, free cash flow, earnings, automotive, medical, acetic acid, VAM